CN107012160A - 高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用 - Google Patents
高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用 Download PDFInfo
- Publication number
- CN107012160A CN107012160A CN201710215454.4A CN201710215454A CN107012160A CN 107012160 A CN107012160 A CN 107012160A CN 201710215454 A CN201710215454 A CN 201710215454A CN 107012160 A CN107012160 A CN 107012160A
- Authority
- CN
- China
- Prior art keywords
- corynebacterium glutamicum
- gene
- genes
- acid
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 title claims abstract description 104
- 241000186226 Corynebacterium glutamicum Species 0.000 title claims abstract description 44
- 238000010276 construction Methods 0.000 title claims abstract description 12
- 229960005137 succinic acid Drugs 0.000 title claims abstract 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 101150023641 ppc gene Proteins 0.000 claims abstract description 11
- 210000000349 chromosome Anatomy 0.000 claims abstract description 10
- 108091081024 Start codon Proteins 0.000 claims abstract description 8
- 101150094017 aceA gene Proteins 0.000 claims abstract description 8
- 101150036393 aceB gene Proteins 0.000 claims abstract description 8
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 claims abstract description 8
- 101150106096 gltA gene Proteins 0.000 claims abstract description 8
- 101100350224 Bacillus subtilis (strain 168) pdhB gene Proteins 0.000 claims abstract description 7
- 101100236536 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) glcB gene Proteins 0.000 claims abstract description 7
- 101100406344 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceF gene Proteins 0.000 claims abstract description 7
- 101150023527 actA gene Proteins 0.000 claims abstract description 7
- 101150042350 gltA2 gene Proteins 0.000 claims abstract description 7
- 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 claims abstract description 6
- 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 claims abstract description 6
- 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 claims abstract description 6
- 101150070136 axeA gene Proteins 0.000 claims abstract description 6
- 101150030499 lnt gene Proteins 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 21
- 101150096049 pyc gene Proteins 0.000 claims description 17
- 230000037361 pathway Effects 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 239000006227 byproduct Substances 0.000 claims description 10
- 108010053763 Pyruvate Carboxylase Proteins 0.000 claims description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000013605 shuttle vector Substances 0.000 claims description 6
- 241000588722 Escherichia Species 0.000 claims description 5
- 108020003285 Isocitrate lyase Proteins 0.000 claims description 5
- 108020004687 Malate Synthase Proteins 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 229940107700 pyruvic acid Drugs 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 244000248349 Citrus limon Species 0.000 claims 1
- 235000005979 Citrus limon Nutrition 0.000 claims 1
- 241000644323 Escherichia coli C Species 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 150000002085 enols Chemical class 0.000 claims 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 abstract description 13
- 239000000126 substance Substances 0.000 abstract description 4
- 101150006213 ackA gene Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 44
- 239000001384 succinic acid Substances 0.000 description 42
- 239000012634 fragment Substances 0.000 description 28
- 239000013612 plasmid Substances 0.000 description 22
- 101150017120 sod gene Proteins 0.000 description 18
- 239000013598 vector Substances 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 12
- 230000004927 fusion Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 238000011144 upstream manufacturing Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 5
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 5
- 101150104734 ldh gene Proteins 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000003209 gene knockout Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 102100034229 Citramalyl-CoA lyase, mitochondrial Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000001130 congenital generalized lipodystrophy type 1 Diseases 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 101150025220 sacB gene Proteins 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102100032230 Caveolae-associated protein 1 Human genes 0.000 description 2
- 101150020392 Cgl3 gene Proteins 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102100030385 Granzyme B Human genes 0.000 description 2
- 101000869049 Homo sapiens Caveolae-associated protein 1 Proteins 0.000 description 2
- 101001009603 Homo sapiens Granzyme B Proteins 0.000 description 2
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 201000001113 congenital generalized lipodystrophy type 3 Diseases 0.000 description 2
- 201000001116 congenital generalized lipodystrophy type 4 Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 2
- 101150026107 ldh1 gene Proteins 0.000 description 2
- 238000012269 metabolic engineering Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 101150103244 ACT1 gene Proteins 0.000 description 1
- 241000948980 Actinobacillus succinogenes Species 0.000 description 1
- 241000722954 Anaerobiospirillum succiniciproducens Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102100031102 C-C motif chemokine 4 Human genes 0.000 description 1
- 101100161935 Caenorhabditis elegans act-4 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 1
- 241000029538 [Mannheimia] succiniciproducens Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 101150078046 act2 gene Proteins 0.000 description 1
- 101150015779 act3 gene Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- -1 dephosphorylases Proteins 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 101150095787 ldh2 gene Proteins 0.000 description 1
- 101150035055 ldh3 gene Proteins 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001937 non-anti-biotic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/03—Acyl groups converted into alkyl on transfer (2.3.3)
- C12Y203/03001—Citrate (Si)-synthase (2.3.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/03—Acyl groups converted into alkyl on transfer (2.3.3)
- C12Y203/03009—Malate synthase (2.3.3.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y208/00—Transferases transferring sulfur-containing groups (2.8)
- C12Y208/03—CoA-transferases (2.8.3)
- C12Y208/03008—Acetate CoA-transferase (2.8.3.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/03—Oxo-acid-lyases (4.1.3)
- C12Y401/03001—Isocitrate lyase (4.1.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y604/00—Ligases forming carbon-carbon bonds (6.4)
- C12Y604/01—Ligases forming carbon-carbon bonds (6.4.1)
- C12Y604/01001—Pyruvate carboxylase (6.4.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/60—Vectors containing traps for, e.g. exons, promoters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用,构建方法为:(1)在谷氨酸棒杆菌ATCC 13032中敲除pta‑ackA基因操纵子、actA基因及ldh基因;在染色体上的ppc基因的起始密码子前和pyc基因的起始密码子前引入Psod强启动子;(2)用pECXK99E连接基因pyc、基因gltA和基因sucE得到pEC‑pycsucEgltA;用pXMJ19连接基因aceA和基因aceB得到pX‑aceAaceB;(3)将pEC‑pycsucEgltA和pX‑aceAaceB导入步骤(1)获得的谷氨酸棒杆菌中,得到高产琥珀酸的谷氨酸棒杆菌菌株。本发明琥珀酸得率高,副产物少。
Description
技术领域
本发明属于生物工程技术与应用领域,具体地涉及一种高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用。
背景技术
2004年,琥珀酸(又名丁二酸)被美国能源部列为十二个最有价值的平台化合物之一,又因其被广泛地用作可降解塑料、食品的鲜味剂和医药中间体的合成原料,所以一直被当作一种高附加值产品而被广大研究者研究。2010年的琥珀酸以及其衍生物的全球市场年需求量就已高达三千万吨,并且将会继续逐年递增。而据2013年的统计结果,琥珀酸年产量尚不足30万吨,市场缺口极大。当前,化学法仍是琥珀酸合成的主要工艺,但随着传统化工产业对环境危害的不断加重,生物发酵合成琥珀酸受到了越来越多的关注。
微生物发酵生产琥珀酸,指的是通过细菌或者真核生物的发酵方法,以淀粉、糖、甘油或其它微生物能够与传统的化学合成法相比较,生物法具有许多优势。首先化学合成法的成本较高且生产过程中伴随着大量重污染的有毒有害的副产物产生。而微生物合成法采用碳水化合物这种可再生原料作为初始碳源,这种方法具有低成本,对环境友好,储备量丰富,可再生等诸多优点。其次,微生物合成琥珀酸的过程中,每生成1摩尔琥珀酸的同时固定1摩尔二氧化碳,因此这种方法不仅摆脱了对石油资源的依赖,减轻当今石油工业的资源短缺的现状,而且开辟了温室气体二氧化碳再利用的新途径。目前对于微生物宿主的选择是多种多样的,包括天然分泌琥珀酸的厌氧微生物以及基因工程菌。研究最多的是:产琥珀酸放线杆菌Actinobacillus succinogenes,产琥珀酸曼氏杆菌Mannheimiasucciniciproducens,产琥珀酸厌氧螺菌Anaerobiospirillum succiniciproducens,大肠杆菌Escherichia coli,酿酒酵母Saccharomyces cerevisiae以及谷氨酸棒杆菌Corynebacterium glutamicum。
谷氨酸棒杆菌是一种兼性厌氧、生长快速的革兰氏阳性菌,作为一株成熟的工业规模氨基酸生产菌株,近年来活跃于各种化学品、生物材料(二元胺、二羧酸、二元醇以及高分子聚合物等)以及生物燃料(乙醇、高级醇等)的生物转化过程中。在厌氧条件下,谷氨酸棒杆菌的细胞生长受到抑制,但是细胞仍有能力进行糖代谢,并大量积累比如L-乳酸,琥珀酸和乙酸等有机酸。因此,研究者们结合代谢工程操作手段与好氧富集菌体-厌氧高密度发酵工艺,在谷氨酸棒杆菌高产琥珀酸方面做出了一定的研究。
南京工业大学通过低能离子束注入技术对谷氨酸棒杆菌进行诱变得到突变株SA001,消除了菌株副产物乳酸的积累,大幅提高了琥珀酸的得率(郝宁,严明,许晟等.一种高产琥珀酸的谷氨酸棒杆菌。申请号CN201010578530.6)。但总体产酸水平较低,且产率偏低。江南大学通过基因工程改造得到的谷氨酸棒状杆菌Δldh-pDXW-8/ppc/pyc基因工程菌通过好氧培养-厌氧高密度发酵,产酸能力有了较大的提升,在厌氧阶段积累了75g L-1(张伟国,刘学胜,钱和等.一种高产丁二酸的谷氨酸棒杆菌工程菌及其构建方法。申请号CN201310080870.X)。但没有针对副产品乙酸生成途径进行改造,琥珀酸得率较低,不利于工业规模放大。
发明内容
本发明的目的是克服现有技术的不足,提供一种高产琥珀酸的谷氨酸棒杆菌菌株。
本发明的第二个目的是提供一种高产琥珀酸的谷氨酸棒杆菌菌株的构建方法。
本发明的第三个目的是提供一种高产琥珀酸的谷氨酸棒杆菌菌株在生产琥珀酸中的应用。
本发明的技术方案概述如下:
高产琥珀酸的谷氨酸棒杆菌菌株的构建方法,包括如下步骤:
(1)在谷氨酸棒杆菌(Corynebacterium glutamicum)ATCC 13032中敲除副产物乙酸生成途径pta-ackA基因操纵子、乙酸生成途径actA基因以及乳酸生成途径ldh基因;在染色体上的回补途径磷酸烯醇式丙酮酸羧化酶ppc基因的起始密码子前引入Psod强启动子,再在染色体上的回补途径丙酮酸羧化酶pyc基因的起始密码子前引入Psod强启动子;
(2)使用大肠杆菌-谷氨酸棒杆菌穿梭载体pECXK99E连接丙酮酸羧化酶基因pyc、柠檬酸合酶基因gltA和琥珀酸输出蛋白基因sucE得到pEC-pycsucEgltA;使用大肠杆菌-谷氨酸棒杆菌穿梭载体pXMJ19连接异柠檬酸裂合酶基因aceA和苹果酸合酶基因aceB得到pX-aceAaceB;(3)将pEC-pycsucEgltA和pX-aceAaceB导入步骤(1)获得的谷氨酸棒杆菌中,得到高产琥珀酸的谷氨酸棒杆菌菌株。
上述方法构建的高产琥珀酸的谷氨酸棒杆菌菌株。
上述高产琥珀酸的谷氨酸棒杆菌菌株在生产琥珀酸中的应用。
有益效果
本发明所构建的高产琥珀酸的谷氨酸棒杆菌菌株,经过98h的厌氧发酵,能够积累110g L-1的琥珀酸,得率为0.87g琥珀酸/g葡萄糖。不仅琥珀酸的产量得到很大的提高,而且减少了副产物的产生,提高了琥珀酸的得率。
附图说明
图1为pD-sacB敲除载体的图谱。
图2为谷氨酸棒杆菌无痕敲除原理示意图。
图3为pD-pta-ackA敲除载体的图谱。
图4为pD-actA敲除载体的图谱。
图5为pD-ldh敲除载体的图谱。
图6为pD-Psod-ppc整合载体的图谱。
图7为pD-Psod-pyc整合载体的图谱。
图8为pEC-pycsucEgltA表达载体的图谱。
图9为pX-aceAaceB表达载体的图谱。
图10为菌株CGL7厌氧条件下分批补料发酵示意图。
具体实施方式
本发明所用到的原始菌株谷氨酸棒杆菌Corynebacterium glutamicum ATCC13032来源为ATCC(The Global Bioresource Center,http://www.atcc.org/),购买于2012年10月。
重组质粒pK18mobsacB,表达质粒pXMJ19和pECXK99E购买于BioVector NTCC公司(http://www.biovector.net/)。
所用琥珀酸标准品从sigma公司(http://www.sigmaaldrich.com/sigma-aldrich)购买。
所用限制性内切酶、去磷酸化酶、DNA连接酶等分子生物学试剂从thermo公司购买(http://www.thermoscientificbio.com/fermentas),所用其他生化试剂从生工生物工程(上海)股份有限公司购买(http://www.sangon.com/)。
厌氧条件下,谷氨酸棒杆菌的琥珀酸生产主要通过三羧酸循环(TCA)的还原臂,而丙酮酸羧化酶pyc及磷酸烯醇式丙酮酸羧化酶ppc是代谢流导向TCA还原臂的关键酶,因此对其进行过表达。同时由于乙醛酸循环途径在合成琥珀酸的过程中对于还原力的需求更低,因此也是很有潜力的琥珀酸生成途径。柠檬酸合酶基因gltA催化草酰乙酸和乙酰辅酶A生成柠檬酸,柠檬酸可以进一步生成异柠檬酸,是乙醛酸循环的重要前体物质。异柠檬酸裂合酶(aceA)催化异柠檬酸生成乙醛酸和琥珀酸,苹果酸合酶(aceB)催化乙醛酸生成苹果酸。为了打通乙醛酸循环,对上述三个酶的基因进行过表达。及时将细胞生成的琥珀酸转运到胞外是琥珀酸生产关键环节之一,因此对琥珀酸输出蛋白基因sucE进行过表达。经检索,目前未见有使用相同代谢工程改造谷氨酸棒杆菌以及利用其生产琥珀酸的报道。
下面结合实施例对本发明做进一步说明,下述实施例是为了使本领域的技术人员能够更好地理解本发明,但对本发明不作任何限制。
实施例1:pD-sacB敲除载体构建以及谷氨酸棒杆菌无痕敲除操作
(1)pD-sacB敲除载体构建
首先以HindIII切割后的pK18mobsacB线性片段作为模板,用引物sacB1/sacB2扩增sacB基因,约1.6kb。
将MunI/EcoRV双酶切的sacB基因连接到EcoRI/SmaI双酶切的pECXK99E上面,然后用如下的引物trcsacB1/trcsacB2,以pECXK99E-sacB质粒作为模板扩增含有trc启动子的trcsacB片段,约1.8kb。用引物pD1/pD2,以pK18mobsacB质粒作为模板扩增含有含有卡那霉素抗性和大肠杆菌复制子的pD片段,约2.6kb。最后将AatII酶切的片段trcsacB和pD进行连接得到pD-sacB。最终的pD-sacB质粒图谱如图1所示。
(2)谷氨酸棒杆菌无痕敲除操作
①基于sacB蔗糖致死原理的无痕敲除,如图2所示:
1.将构建好的敲除载体,如pD-sacB-AC质粒(AC代指欲敲除基因的上游PCR片段A和下游PCR片段C的融合而得的PCR片段AC),通过电极转化到谷氨酸棒杆菌后,涂布于BHIS-Kan15(Kan15,指代培养基中含有终浓度为15ug/mL的卡那霉素)固体平板上,30℃培养48h左右。
2.待菌落长至可挑取大小(直径2-4mm),对点LB-Kan25-Suc100(Kan25,指代培养基中含有终浓度为25ug/mL的卡那霉素,下同;Suc100,指代培养基中含有终浓度为100g/L的蔗糖,下同)与LB-Kan25平板,30℃培养12h,选取不在LB-Kan25-Suc100平板上面生长而在LB-Kan25上面长势良好的菌落挑至无抗LB试管中于30℃,220rpm,过夜培养(12h以上)。
3.无抗LB试管中的菌液稀释50倍,分别取20μL、40μL、60μL、80μL涂布于LB-Suc100平板。同时取稀释50倍菌液的80μL涂布于LB-Kan25-Suc100平板。最后取稀释5000倍的菌液50μL涂布于LB-Kan25平板。30℃培养24h。
4.观察平板长势,只有当LB-Kan25平板上长势良好而LB-Kan25-Suc100平板上却几乎不长时,才可进行下步筛选。从所有LB-Suc100平板上,选取50个单菌落,挑菌至试管培养后进行菌液PCR,电泳检验PCR片段长度,验证正确的重新挑菌至液体LB-Kan25试管中培养验证。
5.抽提无抗LB试管中菌液的基因组,再次进行PCR验证,片段长度与AC相符的即为成功突变的菌株,于-80℃冰箱保存。本发明对谷氨酸棒杆菌无痕敲除操作不做限定,参考文献1中公开了相关方法
其中,BHIS固体培养基:7.4g脑心浸粉与4g琼脂溶于100ml双蒸水,18.2g山梨糖溶于100mL双蒸水;脑心浸粉和山梨糖分开进行0.1Mpa压力下灭菌20min,使用时再等体积混匀。
LB液体培养基配方为:蛋白胨(10g/L),酵母提取物(5g/L),NaCl(10g/L),调节pH至7.0。0.1Mpa压力下灭菌20min。LB液体培养基中添加20g/L的琼脂LB固体培养基。
实施例2:副产物乙酸生成途径pta-ackA基因操纵子、副产物乙酸生成途径actA基因与副产物乳酸生产途径ldh基因的敲除
(1)敲除乙酸生成途径pta-ackA基因操纵子的具体操作如下:
利用pta1、pta2和pta3、pta4两对引物,以C.glutamicum ATCC 13032为模版,使用KOD-plus高保真DNA聚合酶扩增分别得到大小为870bp和929bp的上下游同源臂。经切胶回收后利用引物pta5、pta6,同样使用KOD-plus高保真DNA聚合酶进行融合PCR扩增,得到上下游同源臂的约1.6kb的拼接产物。然后将融合产物和pD-sacB质粒使用Thermo Fast digestXbaI/SalI双酶切,经连接、转化后得到pta-ackA基因操纵子敲除载体pD-pta-ackA(见图3)。将测序结果正确的质粒通过电转导入谷氨酸棒杆菌ATCC 13032中,按照实施例1中所述方法得到pta-ackA基因操纵子敲除菌株CGL1。
(2)敲除乙酸生成途径actA基因的具体操作如下:
利用act1、act2和act3、act4两对引物,以C.glutamicum ATCC 13032为模版,使用KOD-plus高保真DNA聚合酶扩增分别得到大小为802bp和900bp的上下游同源臂。经切胶回收后利用引物act5、act6,同样使用KOD-plus高保真DNA聚合酶进行融合PCR扩增,得到上下游同源臂的约1.7kb的拼接产物。然后将融合产物和pD-sacB质粒使用Thermo Fast digestXbaI/SalI双酶切,经连接、转化后得到actA基因敲除载体pD-actA(见图4)。将测序结果正确的质粒通过电转导入谷氨酸棒杆菌CGL1中,按照实施例1中所述方法得到actA基因敲除菌株CGL2。
(3)敲除乳酸生成途径ldh基因的具体操作如下:
利用ldh1、ldh2和ldh3、ldh4两对引物,以C.glutamicum ATCC 13032为模版,使用KOD-plus高保真DNA聚合酶扩增分别得到大小为723bp和784bp的上下游同源臂。经切胶回收后利用引物ldh1、ldh4,同样使用KOD-plus高保真DNA聚合酶进行融合PCR扩增,得到上下游同源臂的约1.5kb的拼接产物。然后将融合产物和pD-sacB质粒使用Thermo Fast digestEcoRI/HindIII双酶切,经连接、转化后得到ldh基因敲除载体pD-ldh(见图5)。将测序结果正确的质粒通过电转导入谷氨酸棒杆菌CGL2中,按照实施例1中所述方法得到ldh基因敲除菌株CGL3。
实施例3:染色体上回补途径磷酸烯醇式丙酮酸羧化酶ppc基因的起始密码子前引入Psod强启动子、染色体上丙酮酸羧化酶pyc基因的起始密码子前引入Psod强启动子
(1)磷酸烯醇式丙酮酸羧化酶ppc基因强启动子Psod的插入的具体操作如下:
以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。sodppc1和sodppc2用于扩增基因ppc的上游片段(557bp)。sodppc3和sodppc4用于扩增sod基因的启动子(192bp)。sodppc5和sodppc6用于扩增基因ppc的起始片段(563bp)。分别将3个片段切胶纯化回收后,以等摩尔比例的片段作为模板,用sodppc1和sodppc6作为引物,扩增得到三个片段的融合产物(1.3kb)。然后将融合产物和pD-sacB质粒使用Thermo Fast digest XbaI/HindIII双酶切,经连接、转化后得到ppc基因插入染色体强启动子Psod载体pD-Psod-ppc(见图6)。将测序结果正确的质粒通过电转导入谷氨酸棒杆菌CGL3中,按照实施例1中所述方法得到染色体ppc基因插入强启动子Psod菌株CGL4。
(2)丙酮酸羧化酶pyc基因强启动子Psod的插入的具体操作如下:
以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。sodpyc1和sodpyc2用于扩增基因pyc的上游片段(522bp)。sodpyc3和sodpyc4用于扩增sod基因的启动子(192bp)。sodpyc5和sodpyc6用于扩增基因pyc的起始片段(512bp)。分别将3个片段切胶纯化回收后,以等摩尔比例的片段作为模板,用sodpyc1和sodpyc6作为引物,扩增得到三个片段的融合产物(1.3kb)。然后将融合产物和pD-sacB质粒使用Thermo Fast digest XbaI/HindIII双酶切,经连接、转化后得到pyc基因插入染色体强启动子Psod载体pD-Psod-pyc(见图7)。将测序结果正确的质粒通过电转导入谷氨酸棒杆菌CGL4中,按照实施例1中所述方法得到染色体pyc基因插入强启动子Psod菌株CGL5。
实施例4:使用大肠杆菌-谷氨酸棒杆菌穿梭载体pECXK99E过表达丙酮酸羧化酶基因pyc、柠檬酸合酶基因gltA和琥珀酸输出蛋白基因sucE
以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。p-pyc1和p-pyc2用于扩增基因pyc片段(约3kp)。然后将片段和pECXK99E质粒使用Thermo Fastdigest XbaI/HindIII双酶切,经连接、转化后得到pyc基因表达载体pEC-pyc,测序检测无误。以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。p-sucE1和p-sucE2用于扩增基因sucE以及其本身启动子的片段(约2.2kp)。然后将片段和pEC-pyc质粒使用Thermo Fast digest XbaI/SbfI双酶切,经连接、转化后得到pyc、sucE基因表达载体pEC-pycsucE,测序检测无误。以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。p-gltA1和p-gltA2用于扩增基因gltA片段(约1.3kp)。然后将片段和pEC-pycsucE质粒使用Thermo Fast digest SbfI单酶切,经连接、转化后得到pyc、sucE和gltA基因表达载体pEC-pycsucEgltA(见图8),将测序结果正确的质粒通过电转导入谷氨酸棒杆菌CGL5中,得到pECXK99E过表达丙酮酸羧化酶基因pyc、柠檬酸合酶基因gltA和琥珀酸输出蛋白基因sucE的菌株CGL6。
实施例5:使用大肠杆菌-谷氨酸棒杆菌穿梭载体pXMJ19过表达异柠檬酸裂合酶(aceA)和苹果酸合酶(aceB)
以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。p-aceA1和p-aceA 2用于扩增基因aceA片段(约1.3kp)。然后将片段和pXMJ19质粒使用Thermo Fastdigest XbaI/HindIII双酶切,经连接、转化后得到aceA基因表达载体pX-aceA,测序检测无误。以C.glutamicum ATCC 13032基因组为模板,以如下引物进行PCR扩增。p-aceB1和p-aceB2用于扩增基因aceB片段(约2.2kp)。然后将片段和pX-aceA质粒使用Thermo Fastdigest XbaI/HindIII双酶切,经连接、转化后得到aceA和aceB基因表达载体pX-aceAaceB(见图9),将测序结果正确的质粒通过电转导入谷氨酸棒杆菌CGL6中,得到pXMJ19过表达异柠檬酸裂合酶(aceA)和苹果酸合酶(aceB)的CGL7。
本发明中的菌株代号如CGL1~CGL7等是为了方便描述,但不应理解为对本发明的限定。表1菌株构建所用引物序列
实施例6:利用构建的菌株进行两阶段高密度分批补料琥珀酸厌氧发酵
琥珀酸发酵采用两阶段操作法:
第一阶段,取一管CGL7菌株-80℃保藏的对数期种子培养液冰上融化后全部接入装有50mLCGIII液体培养基的500mL锥形瓶中。30℃,220rpm过夜培养,按照10%接种量转接至装有800mlCGIII种子培养基的3000ml锥形瓶,30℃,220rpm振荡培养至后对数期,此时OD600约等于20。
第二阶段,把CGIII培养液无菌转入到预冷的400mL离心管中,4℃,5000g离心15分钟。用4℃预冷的CGXII培养基冲洗回收的菌体一次,用预冷的CGXII培养基重新悬浮菌体,然后将菌体离心转入到1.5L小型发酵罐中,发酵初始OD600约等于110,初始葡萄糖浓度约为36g L-1,添加230mM NaHCO3提供羧化反应所需要的CO2。分别在5.5h,18h和37.5h进行三次补料,包括80%(v/w)葡萄糖母液和固体NaHCO3。整个过程发酵罐保持封闭状态,转速350rpm,采用15M KOH控制发酵pH为6.8-7.0。经98h发酵之后,琥珀酸浓度达到110g L-1(930mM),平均琥珀酸得率为0.87g(g glucose)-1。副产物乙酸浓度为3g L-1,丙酮酸浓度为0.7g L-1(见图10)。
CGIII培养基配方为:葡萄糖(30g L-1),蛋白胨(10g L-1),酵母抽提物(10g L-1),NaCl(10g L-1),3-morpholinopropanesulfonic acid(MOPS)(21g L-1)(pH 7.0)。
CGXII培养基配方为:葡萄糖(30g L-1),(NH4)2SO4(5g L-1),urea(5g L-1),KH2PO4(1g L-1),K2HPO4(1g L-1),MgSO4·7H2O(0.25g L-1),CaCl2(10mg L-1),FeSO4·7H2O(10mg L-1),MnSO4·H2O(0.1mg L-1),ZnSO4·7H2O(1mg L-1),CuSO4·5H2O(0.2mg L-1),NiCl2·6H2O(20μg L-1),biotin(0.4mg L-1),MOPS(21g L-1)(pH 7.0)。
本发明构建的菌株,其基因型为C.glutamicum 13032ΔldhΔpta-ackAΔactA;Psod-pycPsod-ppc,pEC-pycsucEgltA pX-aceAaceB,KanR CmR。其可以利用葡萄糖生产较高浓度较高得率的琥珀酸。
本发明的菌株的构建,其步骤的前后顺序不限定,本领域的技术人员按本发明公开的内容达到本发明的目的均属于本发明的保护范围。
参考文献1A,Tauch A,W,Kalinowski J,Thierbach G,Pühler A(1994)Small mobilizable multi-purpose cloning vectors derived from the E.coliplasmids pK18and pK19:selection of defined deletions in the chromosome ofCorynebacterium glutamicum.Gene 145:69–73.
SEQUENCE LISTING
<110> 天津大学
<120> 高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用
<130>
<160> 44
<170> PatentIn version 3.3
<210> 1
<211> 31
<212> DNA
<213> 人工合成
<400> 1
cgtgccaatt ggataaagca ggcaagacct a 31
<210> 2
<211> 33
<212> DNA
<213> 人工合成
<400> 2
cgtgcgatat cccatcggca ttttcttttg cgt 33
<210> 3
<211> 34
<212> DNA
<213> 人工合成
<400> 3
agctctgacg tcttatcatc gactgcacgg tgca 34
<210> 4
<211> 35
<212> DNA
<213> 人工合成
<400> 4
agctctgacg tccccatcgg cattttcttt tgcgt 35
<210> 5
<211> 37
<212> DNA
<213> 人工合成
<400> 5
agctctgacg tcaaccccag agtcccgctc agaagaa 37
<210> 6
<211> 38
<212> DNA
<213> 人工合成
<400> 6
agctctgacg tcatgatcct ccagcgcggg gatctcat 38
<210> 7
<211> 20
<212> DNA
<213> 人工合成
<400> 7
ccacgaacct tccagatcag 20
<210> 8
<211> 40
<212> DNA
<213> 人工合成
<400> 8
ggaggcatcg gtggaaatca gaatccatcg aagctgcggt 40
<210> 9
<211> 40
<212> DNA
<213> 人工合成
<400> 9
accgcagctt cgatggattc tgatttccac cgatgcctcc 40
<210> 10
<211> 20
<212> DNA
<213> 人工合成
<400> 10
tgagtgaatc ccgcatccga 20
<210> 11
<211> 30
<212> DNA
<213> 人工合成
<400> 11
aggctctaga gactcaccga aatccccaca 30
<210> 12
<211> 30
<212> DNA
<213> 人工合成
<400> 12
atgcgtcgac actcacgcaa ctcctcaaca 30
<210> 13
<211> 20
<212> DNA
<213> 人工合成
<400> 13
aaggaatcgc agaaccgcca 20
<210> 14
<211> 40
<212> DNA
<213> 人工合成
<400> 14
agccgttctt agccaggttg ccggagaaac caaccttgtc 40
<210> 15
<211> 40
<212> DNA
<213> 人工合成
<400> 15
gacaaggttg gtttctccgg caacctggct aagaacggct 40
<210> 16
<211> 20
<212> DNA
<213> 人工合成
<400> 16
gctgcggctg attttgctga 20
<210> 17
<211> 30
<212> DNA
<213> 人工合成
<400> 17
atgcgtcgac gatcatcttc gccgcttcgt 30
<210> 18
<211> 30
<212> DNA
<213> 人工合成
<400> 18
aggctctaga tcacgggaat ttcgcggttg 30
<210> 19
<211> 29
<212> DNA
<213> 人工合成
<400> 19
atcggaattc ccaaggtgcc gacactaat 29
<210> 20
<211> 29
<212> DNA
<213> 人工合成
<400> 20
cggtgatttc gcaactccaa catctcctg 29
<210> 21
<211> 29
<212> DNA
<213> 人工合成
<400> 21
ttggagttgc gaaatcaccg accacgaga 29
<210> 22
<211> 29
<212> DNA
<213> 人工合成
<400> 22
ccggaagctt gcttccagac ggtttcatc 29
<210> 23
<211> 30
<212> DNA
<213> 人工合成
<400> 23
agataagctt aaatccgtga agctggcacc 30
<210> 24
<211> 44
<212> DNA
<213> 人工合成
<400> 24
cccggaataa ttggcagcta taactacttt aaacactctt tcac 44
<210> 25
<211> 44
<212> DNA
<213> 人工合成
<400> 25
gtgaaagagt gtttaaagta gttatagctg ccaattattc cggg 44
<210> 26
<211> 44
<212> DNA
<213> 人工合成
<400> 26
gtcatcgcgt aaaaaatcag tcatgggtaa aaaatccttt cgta 44
<210> 27
<211> 44
<212> DNA
<213> 人工合成
<400> 27
tacgaaagga ttttttaccc atgactgatt ttttacgcga tgac 44
<210> 28
<211> 30
<212> DNA
<213> 人工合成
<400> 28
agattctaga atgcgacggc ggatgttctt 30
<210> 29
<211> 30
<212> DNA
<213> 人工合成
<400> 29
gataaagctt gctgtggcag tgaccaaccg 30
<210> 30
<211> 20
<212> DNA
<213> 人工合成
<400> 30
tagctgccaa ttattccggg 20
<210> 31
<211> 50
<212> DNA
<213> 人工合成
<400> 31
cccggaataa ttggcagcta tagagtaatt attcctttca acaagagacc 50
<210> 32
<211> 40
<212> DNA
<213> 人工合成
<400> 32
gaagatgtgt gagtcgacat gggtaaaaaa tcctttcgta 40
<210> 33
<211> 40
<212> DNA
<213> 人工合成
<400> 33
tacgaaagga ttttttaccc atgtcgactc acacatcttc 40
<210> 34
<211> 30
<212> DNA
<213> 人工合成
<400> 34
gagctctaga ggcaactgcc ttcacaaaga 30
<210> 35
<211> 47
<212> DNA
<213> 人工合成
<400> 35
ccggaagctt aaaggaggac aaccatgtcg actcacacat cttcaac 47
<210> 36
<211> 35
<212> DNA
<213> 人工合成
<400> 36
ctagtctaga ctttaggaaa cgacgacgat caagt 35
<210> 37
<211> 32
<212> DNA
<213> 人工合成
<400> 37
cgcgtctaga accaagaccg ctgttgcagt ga 32
<210> 38
<211> 32
<212> DNA
<213> 人工合成
<400> 38
agatcctgca ggtgcgctta aggggtcaat gc 32
<210> 39
<211> 31
<212> DNA
<213> 人工合成
<400> 39
atatcctgca ggccgtaatc cggaagagtt t 31
<210> 40
<211> 32
<212> DNA
<213> 人工合成
<400> 40
atatcctgca ggctaaattt agcgctcctc gc 32
<210> 41
<211> 49
<212> DNA
<213> 人工合成
<400> 41
agtaagcttg aaaggaggcc cttcagatgt caaacgttgg aaagccacg 49
<210> 42
<211> 33
<212> DNA
<213> 人工合成
<400> 42
acgtctagac tagttgtgga actggccttc ttc 33
<210> 43
<211> 52
<212> DNA
<213> 人工合成
<400> 43
tagtctagag aaaggaggcc cttcagatga ctgaacagga actgttgtct gc 52
<210> 44
<211> 32
<212> DNA
<213> 人工合成
<400> 44
acggatatcg atgcaggtaa gcgtcgaaaa gc 32
Claims (3)
1.高产琥珀酸的谷氨酸棒杆菌菌株的构建方法,其特征是包括如下步骤:
(1)在谷氨酸棒杆菌(Corynebacterium glutamicum)ATCC 13032中敲除副产物乙酸生成途径pta-ackA基因操纵子、乙酸生成途径actA基因以及乳酸生成途径ldh基因;在染色体上的回补途径磷酸烯醇式丙酮酸羧化酶ppc基因的起始密码子前引入Psod强启动子,再在染色体上的回补途径丙酮酸羧化酶pyc基因的起始密码子前引入Psod强启动子;
(2)使用大肠杆菌-谷氨酸棒杆菌穿梭载体pECXK99E连接丙酮酸羧化酶基因pyc、柠檬酸合酶基因gltA和琥珀酸输出蛋白基因sucE得到pEC-pycsucEgltA;使用大肠杆菌-谷氨酸棒杆菌穿梭载体pXMJ19连接异柠檬酸裂合酶基因aceA和苹果酸合酶基因aceB得到pX-aceAaceB;
(3)将pEC-pycsucEgltA和pX-aceAaceB导入步骤(1)获得的谷氨酸棒杆菌中,得到高产琥珀酸的谷氨酸棒杆菌菌株。
2.权利要求1所述的方法构建的高产琥珀酸的谷氨酸棒杆菌菌株。
3.权利要求2所述菌株在生产琥珀酸中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710215454.4A CN107012160A (zh) | 2017-05-15 | 2017-05-15 | 高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710215454.4A CN107012160A (zh) | 2017-05-15 | 2017-05-15 | 高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107012160A true CN107012160A (zh) | 2017-08-04 |
Family
ID=59445102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710215454.4A Pending CN107012160A (zh) | 2017-05-15 | 2017-05-15 | 高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107012160A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110551648A (zh) * | 2018-05-30 | 2019-12-10 | 天津大学 | 发酵木糖生产琥珀酸的谷氨酸棒杆菌及用途 |
| CN110709517A (zh) * | 2018-03-09 | 2020-01-17 | Cj第一制糖株式会社 | 新型启动子和利用其生产l-氨基酸的方法 |
| CN111607601A (zh) * | 2020-04-24 | 2020-09-01 | 天津大学 | 谷氨酸棒杆菌转录调控因子IpsA突变体及应用 |
| CN113699090A (zh) * | 2021-09-09 | 2021-11-26 | 浙江华睿生物技术有限公司 | 一种构建丙酸生产菌的方法 |
| WO2023142862A1 (zh) * | 2022-01-28 | 2023-08-03 | 廊坊梅花生物技术开发有限公司 | 一种生产苏氨酸的重组微生物及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101720357A (zh) * | 2007-04-20 | 2010-06-02 | 器官平衡有限责任公司 | 用于生产琥珀酸的微生物 |
| CN101984046A (zh) * | 2010-12-08 | 2011-03-09 | 南京工业大学 | 一种高产琥珀酸的谷氨酸棒杆菌 |
| CN102102086A (zh) * | 2010-07-22 | 2011-06-22 | 天津大学 | L-乳酸脱氢酶基因缺失的工程菌及其构建方法与应用 |
| CN102803470A (zh) * | 2009-04-02 | 2012-11-28 | 佛罗里达大学研究基金会公司 | 针对生产琥珀酸路径的工程方法 |
-
2017
- 2017-05-15 CN CN201710215454.4A patent/CN107012160A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101720357A (zh) * | 2007-04-20 | 2010-06-02 | 器官平衡有限责任公司 | 用于生产琥珀酸的微生物 |
| CN102803470A (zh) * | 2009-04-02 | 2012-11-28 | 佛罗里达大学研究基金会公司 | 针对生产琥珀酸路径的工程方法 |
| CN102102086A (zh) * | 2010-07-22 | 2011-06-22 | 天津大学 | L-乳酸脱氢酶基因缺失的工程菌及其构建方法与应用 |
| CN101984046A (zh) * | 2010-12-08 | 2011-03-09 | 南京工业大学 | 一种高产琥珀酸的谷氨酸棒杆菌 |
Non-Patent Citations (1)
| Title |
|---|
| 朱年青: "谷氨酸棒杆菌高产琥珀酸的代谢工程改造", 《中国博士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110709517A (zh) * | 2018-03-09 | 2020-01-17 | Cj第一制糖株式会社 | 新型启动子和利用其生产l-氨基酸的方法 |
| EP3763819A4 (en) * | 2018-03-09 | 2021-12-22 | CJ Cheiljedang Corporation | Novel PROMOTOR AND L-AMINO ACID MANUFACTURING METHOD WITH USE THEREOF |
| US11352608B2 (en) | 2018-03-09 | 2022-06-07 | Cj Cheiljedang Corporation | Promoter and a method for producing L-amino acid using the same |
| CN110709517B (zh) * | 2018-03-09 | 2023-05-30 | Cj第一制糖株式会社 | 新型启动子和利用其生产l-氨基酸的方法 |
| CN110551648A (zh) * | 2018-05-30 | 2019-12-10 | 天津大学 | 发酵木糖生产琥珀酸的谷氨酸棒杆菌及用途 |
| CN110551648B (zh) * | 2018-05-30 | 2022-03-15 | 天津大学 | 发酵木糖生产琥珀酸的谷氨酸棒杆菌及用途 |
| CN111607601A (zh) * | 2020-04-24 | 2020-09-01 | 天津大学 | 谷氨酸棒杆菌转录调控因子IpsA突变体及应用 |
| CN111607601B (zh) * | 2020-04-24 | 2022-10-18 | 天津大学 | 谷氨酸棒杆菌转录调控因子IpsA突变体及应用 |
| CN113699090A (zh) * | 2021-09-09 | 2021-11-26 | 浙江华睿生物技术有限公司 | 一种构建丙酸生产菌的方法 |
| WO2023142862A1 (zh) * | 2022-01-28 | 2023-08-03 | 廊坊梅花生物技术开发有限公司 | 一种生产苏氨酸的重组微生物及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jantama et al. | Combining metabolic engineering and metabolic evolution to develop nonrecombinant strains of Escherichia coli C that produce succinate and malate | |
| AU2008228948B2 (en) | Materials and methods for efficient succinate and malate production | |
| EP2054502B2 (en) | Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same | |
| CN101501204B (zh) | 一种利用甘油生产氨基酸的方法 | |
| CN107012160A (zh) | 高产琥珀酸的谷氨酸棒杆菌菌株及构建方法及应用 | |
| CN102174455B (zh) | 生产丁二酸的大肠杆菌基因工程菌及其构建方法与应用 | |
| CN107012161A (zh) | 利用秸秆水解液高产琥珀酸的谷氨酸棒杆菌及构建及应用 | |
| US9115362B2 (en) | Mutant microorganism having high production of cadaverine, and preparation method of cadaverine using same | |
| TW201441367A (zh) | 具有腐胺生產力之微生物及使用其產生腐胺之方法 | |
| CN109321590B (zh) | 利用乙酸生产l-乳酸的基因工程菌及其构建方法和应用 | |
| CN105543214A (zh) | 利用乙酸生产丁二酸的代谢工程大肠杆菌菌株构建方法和应用 | |
| CN103243064A (zh) | 一种大肠杆菌工程菌株及其好氧-微好氧-厌氧全阶段发酵生产琥珀酸的应用 | |
| WO2016104814A2 (en) | Method for producing dicarboxylic acid | |
| CN102154339A (zh) | 一种产丁二酸大肠杆菌基因工程菌株的构建方法 | |
| Liu et al. | A two-stage process for succinate production using genetically engineered Corynebacterium acetoacidophilum | |
| CN103476922A (zh) | 用来源于埃希氏菌(Escherichia sp.)的果糖激酶基因转化的棒杆菌(Corynebacterium sp.)及使用该棒杆菌制备L-氨基酸的方法 | |
| CN111607601B (zh) | 谷氨酸棒杆菌转录调控因子IpsA突变体及应用 | |
| CN106868033A (zh) | 高产手性d‑(‑)‑乙偶姻的谷氨酸棒杆菌菌株及构建及应用 | |
| CN106434772A (zh) | 一株生产l‑苹果酸的基因工程菌及其构建方法和应用 | |
| Becker et al. | Diamines for Bio‐Based Materials | |
| CN117778288A (zh) | 一种通过动态调控TCA途径生产β-丙氨酸的重组基因工程菌及应用 | |
| CN105567748B (zh) | 一种发酵生产丁二酸的方法 | |
| CN116004495B (zh) | 生产β-丙氨酸的重组基因工程菌及其应用 | |
| CN118956716B (zh) | 一种生产L-乳酸的大肠杆重组菌株E.coli Lac、构建方法及其应用 | |
| CN118389394B (zh) | 一种提高l-色氨酸产量的基因工程菌及其构建方法与应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170804 |